STERIS announced decontamination solution for rrespiratory masks
On Apr. 10, 2020, STERIS announced that the FDA issued an Emergency Use Authorization (EUA) for respirator decontamination….
On Apr. 10, 2020, STERIS announced that the FDA issued an Emergency Use Authorization (EUA) for respirator decontamination….
On Apr. 10, 2020, BenevolentAI announced that baricitinib, which it had identified as a potential treatment for COVID-19,…
On Apr. 10, 2020, Terumo BCT and Marker Therapeutics announced the FDA issued an Emergency Use Authorization (EUA)…
On Apr. 10, 2020, Eli Lilly announced it had entered into an agreement with the National Institute of…
On Apr. 9, 2020, James Petrie, a graduate student in applied mathematics at the University of Waterloo in…
On Apr. 9, 2020, BioCryst Pharmaceuticals announced the company has opened enrollment into a randomized, double-blind, placebo-controlled clinical…
On Apr. 9, 2020, Chembio Diagnostics has been selected for use in a Stony Brook Medicine effort to…
On Apr. 9, 2020, Dr. Carl Wesolowski at the University of Saskatchewan discovered that metformin, often used to…
On Apr. 8, 2020, NIH scientists and collaborators report that autoimmunity, a condition in which the bodyメs immune…
On Apr. 8, 2020, Philips announced that the U.S. Government and Philips agreed to team up to increase…
On Apr. 8, 2020, Abbott announced that the FreeStyle Libre 14 day system, a continuous glucose monitoring (CGM)…
On Apr. 8, 2020, Dynavax Technologies announced it had donated 10,000 doses of HEPLISAV-B adult vaccine to help…
On Apr. 8, 2020, PharmaCyte Biotech announced a license agreement with Hai Kang Life Corp. whereby PharmaCyte received…
On Apr. 8, 2020, Vanda Pharmaceuticals and the University of Illinois at Chicago (UIC) announced a research partnership…
On Apr. 8, 2020, Pacific Biosciences announced it is working with commercial, academic and government research teams that…
On Apr. 8, 2020, Bellerophon Therapeutics announced submission of an Investigational New Drug (IND) application to the FDA…
On Apr. 9, 2020, Pfizer announced that the FDA had approved BRAFTOVIᆴ (encorafenib) in combination with cetuximab (marketed…
On Apr. 8, 2020, Chembio Diagnostics announced a second $1.5 million purchase order from UNICEF for multiplex Zika,…
On Apr. 8, 2020, CSL Behring and SAB Biotherapeutics announced a partnership to combat the coronavirus pandemic with…
On Apr. 8, 2020, a team of Texas A&M University researchers led by Michael R. Moreno, in collaboration…
On Apr. 7, 2020, a map of interactions between the novel coronavirus and human proteins is helping scientists…
On Apr. 7, 2020, Pluristem Therapeutics announced preliminary data from its compassionate use program, treating seven patients suffering…
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
On Apr. 7, 2020, Researchers at the University of Iowa and the University of Georgia announced they had…
On Apr. 7, 2020, Harvard University, Massachusetts Institute of Technology, and Stanford University announced they had established and…
On Apr. 6, 2020, Sema4 announced that it is now performing rapid molecular testing for the detection of…
On Apr. 6, 2020, Getinge announced it was ramping up the production capacity stepwise at its production facility…
On Apr. 6, 2020, GSK and Vir Biotechnology announced a binding agreement to enter into a collaboration to…
On Apr. 6, 2020, IGEA Pharma announced that it was starting to supply of a COVID-19 antibody test…
On Apr. 6, 2020, Intravacc announced development of an intranasal vaccine against COVID-19 that will be developed through…